170 related articles for article (PubMed ID: 32357851)
1. Chinese patient with neurofibromatosis-Noonan syndrome caused by novel heterozygous NF1 exons 1-58 deletion: a case report.
Zhang Z; Chen X; Zhou R; Yin H; Xu J
BMC Pediatr; 2020 May; 20(1):190. PubMed ID: 32357851
[TBL] [Abstract][Full Text] [Related]
2. Novel association of neurofibromatosis type 1-causing mutations in families with neurofibromatosis-Noonan syndrome.
Ekvall S; Sjörs K; Jonzon A; Vihinen M; Annerén G; Bondeson ML
Am J Med Genet A; 2014 Mar; 164A(3):579-87. PubMed ID: 24357598
[TBL] [Abstract][Full Text] [Related]
3. A Novel Heterozygous
Qin S; Zhang Y; Yu F; Ni Y; Zhong J
J Clin Res Pediatr Endocrinol; 2023 Nov; 15(4):438-443. PubMed ID: 35633639
[TBL] [Abstract][Full Text] [Related]
4. Independent NF1 and PTPN11 mutations in a family with neurofibromatosis-Noonan syndrome.
Thiel C; Wilken M; Zenker M; Sticht H; Fahsold R; Gusek-Schneider GC; Rauch A
Am J Med Genet A; 2009 Jun; 149A(6):1263-7. PubMed ID: 19449407
[TBL] [Abstract][Full Text] [Related]
5. NF1 gene mutations represent the major molecular event underlying neurofibromatosis-Noonan syndrome.
De Luca A; Bottillo I; Sarkozy A; Carta C; Neri C; Bellacchio E; Schirinzi A; Conti E; Zampino G; Battaglia A; Majore S; Rinaldi MM; Carella M; Marino B; Pizzuti A; Digilio MC; Tartaglia M; Dallapiccola B
Am J Hum Genet; 2005 Dec; 77(6):1092-101. PubMed ID: 16380919
[TBL] [Abstract][Full Text] [Related]
6. Expanding the Noonan spectrum/RASopathy NGS panel: Benefits of adding NF1 and SPRED1.
Witkowski L; Dillon MW; Murphy E; S Lebo M; Mason-Suares H
Mol Genet Genomic Med; 2020 Apr; 8(4):e1180. PubMed ID: 32107864
[TBL] [Abstract][Full Text] [Related]
7. A variable combination of features of Noonan syndrome and neurofibromatosis type I are caused by mutations in the NF1 gene.
Hüffmeier U; Zenker M; Hoyer J; Fahsold R; Rauch A
Am J Med Genet A; 2006 Dec; 140(24):2749-56. PubMed ID: 17103458
[TBL] [Abstract][Full Text] [Related]
8. Different mutations in the NF1 gene are associated with Neurofibromatosis-Noonan syndrome (NFNS).
Baralle D; Mattocks C; Kalidas K; Elmslie F; Whittaker J; Lees M; Ragge N; Patton MA; Winter RM; ffrench-Constant C
Am J Med Genet A; 2003 May; 119A(1):1-8. PubMed ID: 12707950
[TBL] [Abstract][Full Text] [Related]
9. A Neurofibromatosis Noonan Syndrome Patient Presenting with Abnormal External Genitalia.
Işık E; Onay H; Atik T; Solmaz AE; Özen S; Çoğulu Ö; Darcan Ş; Özkınay F
J Clin Res Pediatr Endocrinol; 2020 Mar; 12(1):113-116. PubMed ID: 31088041
[TBL] [Abstract][Full Text] [Related]
10. Is Neurofibromatosis Type 1-Noonan Syndrome a Phenotypic Result of Combined Genetic and Epigenetic Factors?
Yapijakis C; Pachis N; Natsis S; Voumvourakis C
In Vivo; 2016; 30(3):315-20. PubMed ID: 27107091
[TBL] [Abstract][Full Text] [Related]
11. A new nonsense mutation in the NF1 gene with neurofibromatosis-Noonan syndrome phenotype.
Yimenicioğlu S; Yakut A; Karaer K; Zenker M; Ekici A; Carman KB
Childs Nerv Syst; 2012 Dec; 28(12):2181-3. PubMed ID: 22965773
[TBL] [Abstract][Full Text] [Related]
12. Growth Hormone Deficiency in a Child with Neurofibromatosis-Noonan Syndrome.
Vurallı D; Gönç N; Vidaud D; Özön A; Alikaşifoğlu A; Kandemir N
J Clin Res Pediatr Endocrinol; 2016 Mar; 8(1):96-100. PubMed ID: 26758488
[TBL] [Abstract][Full Text] [Related]
13. Neurofibromatosis-Noonan syndrome and growth deficiency in an Iranian girl due to a pathogenic variant in NF1 gene.
Dalili S; Hoseini Nouri SA; Bayat R; Koohmanaee S; Tabrizi M; Zarkesh M; Tarang A; Mahdieh N
Hum Genomics; 2023 Feb; 17(1):12. PubMed ID: 36803953
[TBL] [Abstract][Full Text] [Related]
14. Noonan syndrome and neurofibromatosis type I in a family with a novel mutation in NF1.
Nyström AM; Ekvall S; Allanson J; Edeby C; Elinder M; Holmström G; Bondeson ML; Annerén G
Clin Genet; 2009 Dec; 76(6):524-34. PubMed ID: 19845691
[TBL] [Abstract][Full Text] [Related]
15. Clinical and molecular aspects of an informative family with neurofibromatosis type 1 and Noonan phenotype.
Stevenson DA; Viskochil DH; Rope AF; Carey JC
Clin Genet; 2006 Mar; 69(3):246-53. PubMed ID: 16542390
[TBL] [Abstract][Full Text] [Related]
16. Neurofibromatosis-Noonan Syndrome: A Possible Paradigm of the Combination of Genetic and Epigenetic Factors.
Yapijakis C; Pachis N; Voumvourakis C
Adv Exp Med Biol; 2017; 987():151-159. PubMed ID: 28971455
[TBL] [Abstract][Full Text] [Related]
17. A novel RAB39B mutation and concurrent de novo NF1 mutation in a boy with neurofibromatosis type 1, intellectual disability, and autism: a case report.
Santoro C; Giugliano T; Bernardo P; Palladino F; Torella A; Del Vecchio Blanco F; Onore ME; Carotenuto M; Nigro V; Piluso G
BMC Neurol; 2020 Sep; 20(1):327. PubMed ID: 32873259
[TBL] [Abstract][Full Text] [Related]
18. LEOPARD syndrome (PTPN11, T468M) in three boys fulfilling neurofibromatosis type 1 clinical criteria.
Carcavilla A; Pinto I; Muñoz-Pacheco R; Barrio R; Martin-Frías M; Ezquieta B
Eur J Pediatr; 2011 Aug; 170(8):1069-74. PubMed ID: 21365175
[TBL] [Abstract][Full Text] [Related]
19. Lethal presentation of neurofibromatosis and Noonan syndrome.
Prada CE; Zarate YA; Hagenbuch S; Lovell A; Schorry EK; Hopkin RJ
Am J Med Genet A; 2011 Jun; 155A(6):1360-6. PubMed ID: 21567923
[TBL] [Abstract][Full Text] [Related]
20. Neurofibromatosis-Noonan Syndrome With Primary Amenorrhoea: A Case Report.
Mohapatra I; Samantaray SR
Cureus; 2023 Jul; 15(7):e42098. PubMed ID: 37602003
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
